maropitant has been researched along with Vomiting in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 15 (57.69) | 24.3611 |
| 2020's | 3 (11.54) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, JE; Hess, RS; Silverstein, DC | 1 |
| Fukazawa, E; Harada, K; Ichimata, M; Kobayashi, T; Matsuyama, F; Nakano, Y | 1 |
| Bettschart-Wolfensberger, R; Hartnack, S; Kantyka, ME; Kutter, APN; Meira, C | 1 |
| Cartagena-Albertus, JC; Engel Manchado, J; Moise, A; Montoya Alonso, JA; Moya García, S | 1 |
| Johnson, RA | 1 |
| Cooke, K; Isaza, N; Koh, RB; Robertson, SA; Xie, H | 1 |
| Hay Kraus, BL | 3 |
| Bolotin, D; Brock, WT; Moses, K; Patricelli, K; Quimby, JM | 1 |
| Himelfarb, MA; Litterio, NJ; Lorenzutti, AM; Martín-Flores, M; Zarazaga, MP | 1 |
| Boesch, JM; Campoy, L; Gleed, RD; Kirch, PJ; Learn, MM; Martin-Flores, M; Mastrocco, A; Sakai, DM | 1 |
| Boesch, JM; Campoy, L; Gleed, RD; Learn, MM; Martin-Flores, M; Mastrocco, A; Sakai, DM | 1 |
| Himelfarb, MA; Invaldi, SH; Litterio, NJ; Lorenzutti, AM; Martín-Flores, M; Zarazaga, MP | 1 |
| Keser, GO; Yalcin, E | 1 |
| Boucher, JF; Clemence, RG; Conder, GA; Sedlacek, HS | 1 |
| Boucher, JF; Clemence, RG; Conder, GA; Eagleson, JS; Ramsey, DS; Sedlacek, HS | 1 |
| Boucher, JF; Clemence, RG; Conder, GA; Eagleson, JS; Kincaid, K; Ramsey, DS; Watkins, JA | 1 |
| Trepanier, L | 1 |
| Shukla, A | 1 |
| Alibhai, HI; Lee, K; Mathis, A | 1 |
| Clemence, RG; de la Puente-Redondo, VA; Rowan, TG; Tilt, N | 1 |
| Benchaoui, HA; Clemence, RG; de la Puente-Redondo, VA; Rowan, TG; Siedek, EM; Tilt, N | 2 |
| van Noort, R | 1 |
| Bunger, A; Cox, SR; Hickman, MA; Lin, J; Mahabir, S; McCall, RB; Miskell, C | 1 |
1 review(s) available for maropitant and Vomiting
| Article | Year |
|---|---|
Acute vomiting in cats: rational treatment selection.
Topics: Acute Disease; Animals; Antiemetics; Cat Diseases; Cats; Chlorpromazine; Diarrhea; Famotidine; Indoles; Metoclopramide; Nausea; Ondansetron; Prochlorperazine; Quinolizines; Quinuclidines; Ranitidine; Sucralfate; Vomiting; Weight Loss | 2010 |
17 trial(s) available for maropitant and Vomiting
| Article | Year |
|---|---|
Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate.
Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Glycopyrrolate; Hydromorphone; Nausea; Ondansetron; Quinuclidines; Vomiting | 2021 |
Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis.
Topics: Animals; Antiemetics; Antifibrinolytic Agents; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind Method; Female; Male; Ondansetron; Prospective Studies; Quinuclidines; Tranexamic Acid; Vomiting | 2020 |
Assessment of the administration of maropitant and loperamide to dogs with cancer for the prevention and reduction of adverse effects associated with the administration of paclitaxel.
Topics: Animals; Antidiarrheals; Antiemetics; Antineoplastic Agents, Phytogenic; Diarrhea; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Loperamide; Male; Neoplasms; Paclitaxel; Quinuclidines; Random Allocation; Vomiting | 2019 |
Maropitant prevented vomiting but not gastroesophageal reflux in anesthetized dogs premedicated with acepromazine-hydromorphone.
Topics: Acepromazine; Analgesics, Opioid; Anesthesia, Inhalation; Animals; Antiemetics; Dog Diseases; Dogs; Dopamine Antagonists; Esophagus; Female; Gastroesophageal Reflux; Hydrogen-Ion Concentration; Hydromorphone; Male; Quinuclidines; Vomiting | 2014 |
Effects of maropitant, acepromazine, and electroacupuncture on vomiting associated with administration of morphine in dogs.
Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Dopamine Antagonists; Electroacupuncture; Female; Male; Morphine; Quinuclidines; Vomiting | 2014 |
Efficacy of orally administered maropitant citrate in preventing vomiting associated with hydromorphone administration in dogs.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hydromorphone; Male; Quinuclidines; Vomiting | 2014 |
Effect of dosing interval on efficacy of maropitant for prevention of hydromorphone-induced vomiting and signs of nausea in dogs.
Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Drug Administration Schedule; Female; Hydromorphone; Male; Nausea; Quinuclidines; Vomiting | 2014 |
Chronic use of maropitant for the management of vomiting and inappetence in cats with chronic kidney disease: a blinded, placebo-controlled clinical trial.
Topics: Animals; Cat Diseases; Cats; Double-Blind Method; Kidney Function Tests; Palliative Care; Quinuclidines; Renal Insufficiency, Chronic; Vomiting | 2015 |
Evaluation of the antiemetic efficacy of maropitant in dogs medicated with morphine and acepromazine.
Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dogs; Drug Interactions; Female; Male; Morphine; Prospective Studies; Quinuclidines; Salivation; Single-Blind Method; Vomiting | 2016 |
Evaluation of oral maropitant as an antiemetic in cats receiving morphine and dexmedetomidine.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Antiemetics; Cats; Dexmedetomidine; Female; Hysterectomy; Morphine; Ovariectomy; Prospective Studies; Quinuclidines; Treatment Outcome; Vomiting | 2016 |
Effects of maropitant in cats receiving dexmedetomidine and morphine.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Antiemetics; Cat Diseases; Cats; Dexmedetomidine; Drug Interactions; Female; Injections, Intramuscular; Injections, Subcutaneous; Morphine; Nausea; Quinuclidines; Single-Blind Method; Visual Analog Scale; Vomiting | 2016 |
A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs.
Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hysterectomy; Male; Metoclopramide; Morphine; Nausea; Orchiectomy; Ovariectomy; Quinuclidines; Vomiting | 2017 |
Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs.
Topics: Animals; Antiemetics; Dog Diseases; Dogs; Female; Male; Metoclopramide; Ondansetron; Parvoviridae Infections; Parvovirus, Canine; Quinuclidines; Treatment Outcome; Vomiting | 2017 |
Efficacy of maropitant in preventing vomiting in dogs premedicated with hydromorphone.
Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hydromorphone; Injections, Intramuscular; Male; Preanesthetic Medication; Quinuclidines; Vomiting | 2013 |
Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs.
Topics: Administration, Oral; Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Dog Diseases; Dogs; Female; Least-Squares Analysis; Male; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting | 2007 |
The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe.
Topics: Animals; Antiemetics; Dog Diseases; Dogs; Europe; Female; Male; Quinuclidines; Treatment Outcome; Vomiting | 2007 |
Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs.
Topics: Animals; Antiemetics; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind Method; Female; Male; Motion Sickness; Quinuclidines; Treatment Outcome; Vomiting | 2007 |
8 other study(ies) available for maropitant and Vomiting
| Article | Year |
|---|---|
Evaluation of adverse events in small-breed dogs treated with maropitant and a single dose of doxorubicin.
Topics: Animals; Diarrhea; Dog Diseases; Dogs; Doxorubicin; Neoplasms; Neutropenia; Prospective Studies; Quinuclidines; Vomiting | 2022 |
Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs.
Topics: Animals; Cross-Over Studies; Dogs; Drug-Related Side Effects and Adverse Reactions; Female; Male; Motion Sickness; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting | 2008 |
Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs.
Topics: Animals; Apomorphine; Cross-Over Studies; Dogs; Emetics; Humans; Ipecac; Male; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting | 2008 |
Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs.
Topics: Administration, Oral; Animals; Dogs; Drug-Related Side Effects and Adverse Reactions; Female; Injections, Subcutaneous; Male; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting | 2008 |
Acute pancreatitis attributed to dietary indiscretion in a female mixed breed canine.
Topics: Acute Disease; Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Cell Count; Dehydration; Dog Diseases; Dogs; Female; Medical History Taking; Meloxicam; Pancreatitis; Quinuclidines; Radiography; Tachycardia; Thiazines; Thiazoles; Treatment Outcome; Vomiting | 2010 |
The use of maropitant to prevent vomiting induced by epidural administration of preservative free morphine through an epidural catheter in a dog.
Topics: Anesthesia, Epidural; Animals; Antiemetics; Dog Diseases; Dogs; Male; Morphine; Narcotics; Quinuclidines; Vomiting | 2011 |
[New antiemetics: maropitant citrate].
Topics: Animals; Antiemetics; Quinuclidines; Vomiting | 2007 |
Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats.
Topics: Animals; Cats; Female; Male; Metabolic Clearance Rate; Motion Sickness; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting | 2008 |